GSK plc
Close on Oct 19, 2026
Earnings
Quarterly results announced on Form 8-K, Item 2.02
No earnings releases found
GSK has not filed an earnings release (Form 8-K, Item 2.02) that we could match to a fiscal quarter.
Press releases
Announcements GSK filed with the SEC
US FDA APPROVES HIBSAGO FOR CHRONIC HEPATITIS B
Event dated Oct 21, 2026, from SEC EDGAR
JEMPERLI APPROVED IN MSI-H/DMMR RECTAL CANCER
Event dated Oct 19, 2026, from SEC EDGAR
RIS-REZ POSITIVE EARLY DATA IN LUNG CANCER
Event dated Oct 19, 2026, from SEC EDGAR
DIRECTOR/PDMR SHAREHOLDING
Event dated Oct 15, 2026, from SEC EDGAR
DIRECTOR/PDMR SHAREHOLDING
Event dated Oct 14, 2026, from SEC EDGAR
DIRECTOR/PDMR SHAREHOLDING
Event dated Oct 13, 2026, from SEC EDGAR
DIRECTOR/PDMR SHAREHOLDING
Event dated Oct 13, 2026, from SEC EDGAR
WENDY BECKER CBE - NEW DIRECTORSHIP
Event dated Oct 8, 2026, from SEC EDGAR
ADMISSION TO TRADING
Event dated Oct 6, 2026, from SEC EDGAR
TOTAL VOTING RIGHTS
Event dated Oct 1, 2026, from SEC EDGAR
DIRECTOR/PDMR SHAREHOLDING
Event dated Sep 24, 2026, from SEC EDGAR
DIRECTOR/PDMR SHAREHOLDING
Event dated Sep 22, 2026, from SEC EDGAR
GSK TO ACQUIRE T CELL-ENGAGER FOR MULTIPLE MYELOMA
Event dated Sep 15, 2026, from SEC EDGAR
Current report on Form 6-K
Event dated Sep 15, 2026, from SEC EDGAR
RIS-REZ POSITIVE PH 3 OS LUNG CANCER DATA IN CHINA
Event dated Sep 14, 2026, from SEC EDGAR